Form D · Biotechnology

Ambient Biosciences, Inc.

Ann Arbor, MI · CIK 0001753668

Offering snapshot reported Dec 2, 2024 · SEC filing

Reported sold
$4.16M
Offering amount: $5M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 22, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 2, 2024Initial$4,160,002No comparison9SEC filing
Apr 13, 2023Initial$9,150,001No comparison8SEC filing
Dec 7, 2021Initial$4,000,000No comparison1SEC filing
Sep 20, 2018Initial$7,000,000No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-530795
Warrants to purchase 253,661 shares of Series A preferred stock were also issued in connection with the offering. The total offering and amount sold exclude proceeds of up to $416,005 from the exercise of the warrants.

Source: Form D, filed Dec 2, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steve Annear Executive
Matthew Cobbett Executive
Jack Hoppin Director
Carl Le Souef Director, Executive
Craig Manson Executive
Paul Meister Director
Pravansu S. Mohanty Director, Executive
William U. Parfet Director
Richard Troyer Executive
Alan Turfe Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1600 Huron Parkway Bldg 520, Rm 2390
Ann Arbor, MI, 48109